Literature DB >> 11463555

Risk analysis and long-term survival in patients undergoing resection of T4 lung cancer.

A Bernard1, O Bouchot, O Hagry, J P Favre.   

Abstract

OBJECTIVE: The aim of this study is to identify the risk group of patients with T4 lung cancer who could more likely benefit from surgical resection.
METHODS: Between January 1, 1990, and December 31, 1998, 77 patients underwent pulmonary resection for T4 lung cancer: lobectomy (n = 20), bilobectomy (n = 4) and pneumonectomy (n = 53). The T4 sites of mediastinal involvement were: Intrapericardiac portions of the pulmonary artery (n = 30), left atrium (n = 19), aorta (n = 8), superior vena cava (n = 8), carina (n = 7), the esophagus (n = 8) and the vertebral body (n = 6). Ten patients had multiple neoplastic nodules in the same lobe of the lung.
RESULTS: Overall survival rates at 1, 2 and 3 years were 46, 31 and 21%, respectively. Factors adversely affecting survival with univariate analysis included the localization of tumours in the lower lobe (P = 0.04) and both the involvement of superior and inferior mediastinal lymph nodes (P = 0.03). Multivariate analysis included two factors adversely affecting survival: the location of the primary tumour and the nodal stations involved. Regression tree analysis classified the patients into low-risk group (primary tumour in upper lobe or in main stem bronchus and pN0 or pN1 or superior or inferior mediastinal nodes involved), intermediate-risk group (primary tumour in upper lobe or in main stem bronchus and both superior and inferior mediastinal nodes involved, primary tumour in inferior lobe and pN0 or pN1 or inferior mediastinal nodes involved) and high-risk group (primary tumour in inferior lobe and both superior and inferior nodes involved). The 3-year survival rates were 36% for the low-risk group, 4% for the intermediate-risk group and 0% for the high-risk group (P = 0.006).
CONCLUSIONS: In patients with T4 lung cancer, the surgery can justify itself for tumours in the upper lobe or in the main stem bronchus and with pN0 or pN1.

Entities:  

Mesh:

Year:  2001        PMID: 11463555     DOI: 10.1016/s1010-7940(01)00788-6

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  7 in total

1.  Surgical results and long-term follow-up of T(4)-non-small cell lung cancer invading the left atrium or the intrapericardial base of the pulmonary veins.

Authors:  Franco Stella; Andrea Dell'Amore; Guido Caroli; Giampiero Dolci; Nicola Cassanelli; Giulia Luciano; Fabio Davoli; Alessandro Bini
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-01-22

2.  Atrial resection for lung cancer: morbidity, mortality, and long-term follow-up.

Authors:  Andreas Kuehnl; Michael Lindner; Hans-Martin Hornung; Hauke Winter; Karl-Walter Jauch; Rudolf A Hatz; Christian Graeb
Journal:  World J Surg       Date:  2010-09       Impact factor: 3.352

Review 3.  Extended resections of non-small cell lung cancers invading the aorta, pulmonary artery, left atrium, or esophagus: can they be justified?

Authors:  Emily S Reardon; David S Schrump
Journal:  Thorac Surg Clin       Date:  2014-09-11       Impact factor: 1.750

4.  Squamous cell carcinoma of the lung invaded to esophagus: a case report of successful surgical treatment after preoperative transesophageal echographic evaluation.

Authors:  Tomohiro Haruki; Hiroshige Nakamura; Satoru Kishimoto; Youhei Yurugi; Shinji Fujioka; Ken Miwa; Yuji Taniguchi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-05-16

5.  Surgical resection and survival of patients with unsuspected single node positive lung cancer (NSCLC) invading the descending aorta.

Authors:  Peter Wex; Thomas Graeter; Francesco Zaraca; Victor Haas; Steffen Decker; Hansanali Bugdayev; Heinrich Ebner
Journal:  Thorac Surg Sci       Date:  2009-07-14

Review 6.  Extended pneumonectomy for advanced lung cancer with cardiovascular structural invasions.

Authors:  Shi-Min Yuan
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2018-04-30       Impact factor: 0.332

7.  Location of stage I-III non-small cell lung cancer and survival rate: Systematic review and meta-analysis.

Authors:  Hyun Woo Lee; Chang-Hoon Lee; Young Sik Park
Journal:  Thorac Cancer       Date:  2018-09-27       Impact factor: 3.500

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.